A blogger with 500,000 monthly readers cofounded an AI blog automation tool that he says is at $350K ARR
Ryan Robinson spent over 12 years building an audience before launching RightBlogger, which had customers immediately.
Subject: RightBlogger (Ryan Robinson)Subscription AI blog automation platform for agencies, content teams and creators
Case Overview & Background
Ryan Robinson has blogged for more than 15 years. His blog about blogging and SEO reaches around 500,000 monthly readers, and he also runs a YouTube channel and a B2B content agency. In 2023 he cofounded RightBlogger with Andy Feliciotti, which has grown to more than 50,000 users after pivoting to full blog automation.
How AI Is Used
Step-by-Step Process
He grew a blog, YouTube channel and agency for years before launching.
RightBlogger had paying customers in its first week.
Product fit came after moving to full blog automation.
Customer Acquisition & Distribution
Limitations, Risks & Failure Modes
What may not apply to you, and what could go wrong:
- The figures are self-reported and were not independently checked
- Mass AI content can be penalized by search engines
- Growth relied on an audience built over 12 years
Key Takeaways
- Pick an audience before you pick a product
- AI automation tools sell well to people already doing the work by hand
Sources
Indie Hackers: Hitting $29k MRR by building an audience first
Note: Founder interview by James Fleischmann. States the $350k ARR and $29k MRR figures and what the AI platform does.
Category page banner: Reach readers researching one specific AI business model.
One clearly labelled banner on a category page such as Micro-SaaS or AI Agencies, shown next to the documented cases your product is relevant to.
Sponsored placements are always labelled and never change how cases are researched, labelled, or ranked.
Commercial disclosure: We currently have no affiliate or sponsorship relationship with any tool or person on this page. If that changes, affiliate links and sponsored content will be clearly labelled, and evidence labels will never be changed for commercial reasons.
